The Journal of Tamilnadu Ophthalmic Association

is a quarterly, peer reviewed journal devoted to the dissemination of the latest in ophthalmology to practitioners all over the state and country. A new Editorial board would be assuming charge soon. Editorial board invites submission of original work dealing with clinical and research work for the issue starting from January 2016.

JTNOA policy:

Our policy is to provide a broad mix of articles that will be of educational value to Ophthalmologists, sub/super specialists and trainees, and to seek innovative and attractive ways in which to deliver a comprehensive programme of professional development. Our priorities are to:

  • Publish up-to-date guidance on clinical management.
  • Harness the latest technologies to promote access to a full range of educational resources.
  • Continue to develop specialist areas of publication that deal with legal, ethical, ethnic and historical issues that are relevant to the science and practice of clinical ophthalmology.
  • Publish contentious issues that are of educational importance.
  • Ensure that a fair, independent peer review system is in place.
  • Adhere to the highest ethical standards concerning research conduct.

Types of Manuscripts

Articles can be submitted as Research Papers, Research Briefs, Reviews, Perspective, Images, Clinical videos, Case Reports, Research Letters, Clinico-Pathological Conference, and Correspondence.

  • Research Papers
  • Research Briefs
  • Review Article
  • Drug Review
  • Clinical Perspective
  • Clinical Update
  • Clinical Practice Guidelines/Recommendations
  • Case Reports
  • Clinico-pathological Conference (CPC)
  • Research Letters
  • Correspondence
  • Photoquiz / Images
  • Clinical Videos
  • Journal / Book Review
  • Industry Update / Opticians Corner
  • Historical / Remembering the past

Manuscript Submission

All manuscripts must be submitted online by email to the editorial office (editorjtnoa@gmail.com). The submissions should be made in MS Word, with double spacing, margins, font size of 12. We are in the process of trying to create an online submission portal, the information regarding which will be soon provided.

Editorial Process

The manuscripts will be reviewed for possible publication with the understanding that they are being submitted to one journal at a time and have not been published, simultaneously submitted, or already accepted for publication elsewhere. All manuscripts submitted to this journal will be sent for peer review process by any two experts in their respective fields, in a blinded fashion.

The authors will be sent intimation regarding the receipt of the article, and will be updated regarding the status of review process regularly. Any corrections in the manuscript suggested for accepted articles should be sent back within 10 days .

A covering letter must be enclosed and should include a statement regarding transfer of copyright of the work to the Journal of Tamilnadu Ophthalmic Association

Preparation of the Manuscript

Covering letter (including statement of copyright transfer)

Title Page

  • Type of manuscript
  • Title of the Article
  • The name of each author (Last name, first name , initials of second name with his / her highest academics degree(s) and institutional affiliation , email address
  • Corresponding Authors name, institutional affiliation and email address
  • The total number of pages and photographs , word counts for the abstract and text
  • Financial disclosure and sources of support (grants / equipments / drugs…)
  • Registration number of clinical trials registry

Abstract

For original articles state the aims, materials and methods, statistical analysis, results and conclusion followed by three to five key words. Abstract need not be structured for review articles, case reports and current research.

Introduction

State the purpose and summarize the rationale for the study or observation.

Materials and Methods

This will include the selection criteria for cases / participants clearly and method of selection, randomization, blinding. State the methods, apparatus, procedure, drugs and chemicals used including routes of administration in sufficient detail.

Ethics

When reporting experiments on human subjects / animals please indicate if the procedures followed were in accordance with the ethical standards of the responsible committee.

Statistics

Specify the statistical methods used to analyze the results.

Results

Present your results in a logical sequence. Do not repeat in the text all the data from tables, graphs and illustrations, summarize only the important observations. Do not duplicate data in graphs and tables.

Tables – Number the tables consecutively in the order in which it is cited in the text, and supply a brief title for each.

• Figures – should be in JPEG format / TIFF format with a minimum resolution of 300 dpi , upto 1 MB while uploading. Each figure should be numbered consecutively in the order in which it is cited in the text. Include legends for each figure (upto 40 words) with Arabic numerals corresponding to the illustrations.
• Protection of Patients’ Rights to Privacy: Identifying information should not be published in written descriptions, photographs, sonograms, CT scans, etc., and pedigrees unless the information is essential for scientific purposes and the patient (or parent or guardian) gives written informed consent for publication. Authors should mask patients’ eyes and remove patients’ names from figures unless they obtain written consent from the patients and submit written consent with the manuscript. When informed consent has been obtained, it should be indicated in the article and copy of the consent should be attached with the covering letter

Discussion

Include summary of key findings, strength and limitations of the study, interpretations and implications, controversies raised by this study, future research directions .

References

Should be numbered consecutively in the order in which they appear in the text. Identify the references in text, tables and legends by Arabic numerals in superscript. Use the style based on the formats used by the NLM in Index MEDICUS. List the first six contributors followed by et al.

Types of Manuscripts and Limits

Articles can be submitted as Research Papers, Research Briefs, Reviews, Perspective, Images, Clinical videos, Case Reports, Research Letters, Clinico-Pathological Conference, In a Lighter vein, and Correspondence.

Research Papers:

The submission should report research relevant to clinical ophthalmology including randomized clinical trials, other intervention studies, studies of screening and diagnostic tests, analytical cohort and case-control studies, systematic reviews and cost-effectiveness analyses. Descriptive studies, case records/series and secondary analyses of data are not preferred for this section.

Each manuscript should be accompanied with an 8-point structured Abstract in not more than 250 words. The text should be arranged in sections on Introduction, Methods, Results and Discussion. Key messages should be provided at the end of the manuscript in a box under headings: ‘What is Already Known?’ and ‘What this Study Adds?’.

As far as possible, authors should restrict to a one line answer for each of these two queries. Number of tables and figures should be limited to a maximum of 4 and 2, respectively. Extra tables and figures, subject to clearance by editorial review process, may be made available only at the journal website. The typical text length for such contributions is 1500-2000 words (excluding title page, abstract, tables, figures, acknowledgments, key messages and references). Number of references should be limited to 25.

Research Briefs:

Brief accounts of descriptive, observational studies, epidemiological assessments, and surveys are published as Research Briefs. Some of the manuscripts submitted as ‘Research Papers’ may also be considered for publication under this section at the discretion of editors. A reasonably large series of cases can also be considered for this section.

Abstract should be limited to 100 words, and structured using the following headings: Objective, Methods, Results, and Conclusions. Provide 2-3 key words, selected from the MESH option of PubMed. The text should contain no more than 1000 words, 2 illustrations/tables and up to 15 recent references. The text should be arranged in order of Introduction, Methods, Results and Discussion. Also include a box entitled ‘What this Study Adds?’, highlighting the main result of the study. The number of authors should be limited to five.

The distinction between Research Brief and Research Paper is purely the journal’s prerogative and does not reflect on the originality of the research submitted. The primary purpose of having a category of ‘Research Brief’ at the time of submission is that these papers can be presented in much fewer words and a slightly different format than Research Papers. However, this category will only last till the manuscript is edited; after editing, all these manuscripts will be given the heading of Research Papers.

Review Article :

State-of-the-art review articles or systematic, critical assessments of literature are also published. The authors may consult the Editor-in-Chief before submitting such articles, as similar reviews may already be in submission.
Normally, a review article on a subject already published in JTNOA in last 3 years is not accepted. The typical length for review articles is 2500-3000 words(excluding tables, figures, and references). Authors submitting review articles should include an abstract of around 200 words describing the need and purpose of review, methods used for locating, selecting, extracting and synthesizing data, and main conclusions. The number of references should be limited to 50. The number of authors should be limited to four.

Drug Review :

JTNOA publishes state of the art reviews on drugs/agents meant for therapeutic or prophylactic use in adults/children. It is expected that the authors have sufficient credible experience in the related field. The following guidelines should be adhered to when preparing a drug review:

  • Drug should be recently developed and should be available commercially (in India) for use in human subjects. Reviews related to agents under research and development, are generally not accepted.
  • Drug should preferably belong to a new class of drugs or having substantial difference in properties and not just an addition to the existing drugs having many similar properties/actions in that class/group of compounds.
  • The drug should have the potential to be used on a large scale for ophthalmic conditions.
  • The drug and related review should have the potential to influence ophthalmic practice, policy and research related issues.
  • The review should be a systematic, critical assessment of the literature and not just an elaboration of the information already provided by pharmaceutical companies.

Clinical Perspective:

Articles should cover challenging and controversial topics of current interest in Ophthalmic health care and the intersection between medicine and society. Some of the manuscripts submitted as ‘Review Articles’ may also be considered for publication under this section at the discretion of editors. The following guidelines need to be followed:

  • Number of authors should be limited to maximum of three.
  • The topic should be specific and related to child health in general.
  • Word limit: 2000 words and may include one figure and one table.
  • Unstructured abstract of up to 150 words.
  • The views should be supported by appropriate evidence and references. Number of references should be limited to a maximum of 25.

Update:

Short write-ups on recent modifications/revisions of standard Guidelines, Classifications or Recommendations issued by Global organizations on topics of interest to pediatricians are published in this section. The word limit is 1000 words, author limit is three, and a maximum of 2 tables and 10 references are allowed. It is preferable that the most relevant changes from the previous version are provided in a tabular form. The manuscript should preferably include an ‘Introduction’ detailing the current status of the disease/guideline and the need for the revision, important changes in the new version, and the implications of the changes.

Clinical Practice Guidelines/Recommendations:

In order to streamline the diagnosis, management and prevention of various ophthalmic problems, JTNOA periodically publishes guidelines and recommendations formulated by various Chapters and Task Forces constituted by AIOS / TNOA or a similar National association/society.
The 8 desirable attributes of practice guidelines are validity, reliability and reproducibility, clinical applicability, flexibility, clarity, documentation, development by a multidisciplinary process, and plans for review.
In order to maintain uniformity of reporting and improve readability and applicability of these practice guidelines, the following 10-point policy should be followed:

  • The Guideline/Recommendation should have been formalized through a consultative meeting/conference/workshop having a National representation approved by AIOS /AAO / SEAGIG / TNOA or a similar society. The Guidelines emerging out of one such meeting should be preferably presented in a single paper.
  • The date(s) and place of such meeting should be clearly mentioned in the Introduction. The names of the chairperson, convener and participants should be listed as ‘Annexure’ at the end of the draft.
  • For indexing purposes, the author of the guidelines should preferably be the name of the organization/working group e.g., AIOS legal cell, expert group. However, names of up to six persons as writing committee may be included in the
  • The final guidelines should be cleared by the related Society/Chapter. A letter to this effect should be enclosed. The corresponding author must obtain permission from all members of the committee/expert group to act in this capacity.
  • The manuscript should consist of an Abstract (250-300 words), Text (3000-4000 words), and References (limited to 50). The number of figures and tables should be limited to maximum of 5 each.
  • Abstract should be structured as Justification, Process, Objectives, and Recommendations.
  • Text should be arranged in headings of Introduction, Aims and Objectives, and Recommendations.
  • Introduction: Justify the need of formulating the guidelines/recommendations in a brief paragraph followed by the process of arriving at the guidelines/recommendations. Describe the methods used to search the literature, and criteria used to grade the quality of evidence.
  • Aims and Objectives: Should clearly state (in doable terms, using action verbs) the terms of reference of the consultative meeting/ conference/ workshop. List 2-3 main objectives only.
  • Text: The main text of the Guidelines/Recommendations should be mentioned under the same terms of reference as per aims and objectives outlined earlier. Preferably, provide level of evidence for each major recommendation.
  • The Recommendations should not provide ‘Review of literature’ or ‘What is already known’. Background material on the concerned subject will not be published.
  • If guidelines are adapted from statement of some other society or from earlier recommendations, only changes need to be highlighted (preferably in a tabular form) without repeating the detailed guidelines. However, if there is a pressing need to repeat the recommendations, it should be done after taking permission from the parent society/journal (as applicable) clearly mentioning and citing the source.
  • State, whether or not there is a plan to review these guidelines and an expiration date for this version of the guideline.. Any competing interest, including funding support, should be declared.

Case Reports:

Clinical cases highlighting some unusual or new but “clinically relevant” aspects of a condition are published as Case Reports. Case reports should highlight some new or unusual aspect regarding etiopathogenesis, diagnosis or management of an ophthalmic condition that adds to the existing body of knowledge. Rarity of the reported condition alone will not be a criterion for acceptance.

Genetic syndromes not reporting novel mutations explaining patho-physiology and/or genotype-phenotype correlation will be sent back to authors without initiating the peer review process. Minor or clinically insignificant variations of rare but well-known disorders are also not preferred.

The text should not exceed 1000 words and should be arranged as introduction, case report and discussion. Include a brief structured abstract of 50 words using the following headings: Background, Case characteristics, Intervention/Outcome, and Message. Only one very relevant figure is allowed. Include up to 10 most recent references.

Only color photographs should be submitted; black-and-white images will not be entertained. Color images will be published only in the web-version of the journal; for print version, these will be converted to black and white.

A maximum of three authors are permitted from a single department. Case reports involving more than one department can have one additional author from each department (not from subspecialties within the same department).

The patient’s written consent (or that of the next of kin) to publication must be obtained, and the same must be affirmed/stated on the Title page.

Clinico-pathological Conference (CPC):

The clinico-pathological conference, a method of case-based teaching, is frequently used in institutions and primarily consists of a logical, narrowing of the differential diagnosis in a patient.

JTNOA publishes CPCs, provided they fulfil the following criteria:

  • At least three different departments are involved in the CPC, with each providing significant contribution to the discussion.
  • The case represents a problem likely to be seen in the routine ophthalmic settings in India. They patient may later-on be diagnosed with a rare condition, but the initial presentation should be mimicking a common condition.
  • The write-up should be given following headings: (i) Clinical Protocol; (ii) Pathology Protocol; (iii) Open Forum; (iii) Discussion; and (iv) References.
  • The typical word count for this section is 2500-3000 words with upto 15 references. Up to two persons from the primary department and one person from each of the associated department may be included as the author of the manuscript.

Research Letters:

Under this heading, short correspondence pertaining to research would be included. Research Letters reporting original research should not exceed 500 words of text and 10 references. They may have no more than five authors; other persons who have contributed to the study may be indicated in acknowledgment section, with their permission.

Unstructured abstract of up to 50 words reporting the key findings should also be included. Letters must not duplicate other material published, submitted or planned to be submitted for publication. Although unstructured, the text should follow the general sequence of introduction, methods, results and discussion, and all other guidelines in ‘Preparing the Manuscript’.

Correspondence:

Letters commenting upon recent articles in JTNOA are welcome. Such letters should be received within 3 months of the article’s publication. Letters commenting on ‘Case Reports’ and ‘Correspondence’, are generally not preferred.

At the Editorial board’s discretion, the letter may be sent to the authors for reply and the letter alone or letter and reply together may be published after appropriate review. Letters may also relate to other topic of interest to pediatricians, or useful clinical observations.

Letters should not have more than 400 words; and 5 most recent references. The text need not be divided into sections. The number of authors should not exceed two, including the authors’ reply in response to a letter commenting upon an article published in JTNOA.

In the latter case, inclusion of only one of the authors (of the article in question) is permissible along with the corresponding author. Names of additional persons who have helped in drafting the letter can be mentioned in the acknowledgment section.

Photoquiz / Images:

Only clinical photographs with/without accompanying skiagrams or pathological images are considered for publication. Image should clearly identify the condition and have the classical characteristics of the clinical condition. Clinical photograph of conditions that are very common, extremely rare, where diagnosis is obvious.

A short text of about 150 words should be provided in two paragraphs; first paragraph having description of condition, and second paragraph discussing differential diagnosis and management. Figures should be submitted separately from the text file. The electronically submitted images should be of high resolution (>300 dpi). The following file types are acceptable: .cdr, .tiff, and .jpeg. A maximum of two authors are permitted.

Images of cases involving more than one department can have a maximum of three authors. The authors should ensure that images of similar nature have not been published earlier in JTNOA. Authors must obtain signed informed consent from the parent/legal guardian, and the same must be stated on the Title page. The editorial board may ask for such a consent form at any time during the manuscript review process. Manuscript having poor quality or inappropriate resolution images may be returned to author for improvement at any stage of manuscript handling.

Clinical Videos:

Under this section, JTNOA publishes videos depicting an intricate technique or an interesting clinical manifestation, which are difficult to describe clearly in text or by figures. A video file submitted for consideration for publication should be of high resolution and should be edited by the author in final publishable format. MPEG or MP4 formats are acceptable. The maximum size of file should be 20 MB, and it should be submitted as a supplementary file with the main manuscript.

The file should not have been published elsewhere, and will be a copyright of JTNOA, if published. In case the video shows a patient, he/she should not be identifiable. In case the identification is unavoidable, or even otherwise, each video must be accompanied by written permission of parent/guardian, as applicable.

A write-up of up to 250 words discussing the condition and its differential diagnoses must accompany the video. A still image/thumbnail from the video should be submitted as a figure (.jpeg, .tiff or .cdr format) for use in print version and pdf of the finally published version. The main text file should also be accompanied with a legend for video. A maximum of three authors, including a maximum of two from primary department are permitted for this section. No references are needed.

Alternate issues:

Journal / Book Review
Should briefly comment on the highlights of any current book / journal article with a word count of up to 800

Industry Update / Opticians Corner
A brief report from manufacturers of equipments, instruments, drugs , opticians about any product launched recently in the market for a page ( up to 500 words) , which can be followed by the relevant product advertisement.

Historical / Remembering the past
This section will include a brief history of the person credited for important inventions in ophthalmology, and how they stumbled upon their path breaking ideas with a limit of word count for text up to 1500.

KINDLY SUBMIT /SENT YOUR PAPERS /ARTICLES/LETTER TO EDITOR

– editorjtnoa@gmail.com

Dr.T. Nirmal Fredrick
Editor, Journal of TNOA,

Office: Nirmals Eye Hospital,
#108, Ayyasamy Street, West Tambaram,
Chennai 600045

Email editorjtnoa@gmail.com / nirmalfred@yahoo.co.in
Mobile: 9840746062